researchers have developed a new artificial intelligence-based software which may identify and measure the severity of common causes of strokes and
.: "arise: a phase 3 randomized trial of erenumab for episodic migraine."
.
marketwatch: "new migraine drugs have promise -- and a ,500 price tag."
.